Researchers evaluated if two recently developed risk scores can anticipate adverse in-hospital outcomes after PCI, sharing their findings in the American Journal of Cardiology.

Clopidogrel monotherapy after just one month of DAPT was associated with promising outcomes, including a reduction in bleeding events.

Peter Libby, MD, a cardiovascular medicine specialist at Brigham and Women’s Hospital, explains his research into COVID-19 and how it damages the endothelium of blood vessels. 

Cardiac amyloidosis can be especially challenging to identify and diagnose, making it a perfect target for advanced AI models.

The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients. 

The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a joint statement aimed at updating the rules and regulations associated with randomized clinical trials

Postural orthostatic tachycardia syndrome is a significant, but treatable condition. The risk among COVID-19 patients was considerably higher than the risk after vaccination, researchers explained. 

High out-of-pocket costs are a growing problem in healthcare, often creating stress and confusion for patients. A new analysis in Circulation: Cardiovascular Quality and Outcomes examined one way that physicians can help.